<em id="jjnnf"><span id="jjnnf"><listing id="jjnnf"></listing></span></em><form id="jjnnf"></form>
<listing id="jjnnf"></listing><pre id="jjnnf"><delect id="jjnnf"></delect></pre>

        <form id="jjnnf"></form>
          <font id="jjnnf"><thead id="jjnnf"></thead></font><meter id="jjnnf"><font id="jjnnf"><font id="jjnnf"></font></font></meter>
            <output id="jjnnf"><mark id="jjnnf"></mark></output>

                  <form id="jjnnf"><address id="jjnnf"><listing id="jjnnf"></listing></address></form>

                       
                     
                     
                     
                     
                     
                       
                      Timeline        
                         
                     
                    pointer Franco-Indian Pharmaceuticals Pvt. Ltd. was established on 1st May, 1949 by Mr. M. Postel, a French National, in Bombay, as FRANCO-INDIAN UNITED LABORATORIES.
                    pointer The year FIPPL was established, the pharma market was relatively mid–sized and all the major drugs were imported. The Indian market had very few manufacturers.
                    pointer FIPPL entered the IPM with the introduction of OTC products. These products were not so successful because their propaganda was only through daily newspapers and Ayurvedic drugs were preferred.
                    pointer FIPPL then started scientific promotion to medical professionals and introduced:
                     
                    pointer NEVROVITAMINE 4 Adults
                    pointer NEVROVITAMINE 4 'Children'
                    pointer ULTRAVITAMINE 4
                    pointer GLUXIUM
                    pointer Along with the marketing of various hormones under license from abroad, FIPPL also introduced 3 forms of VITAMIN D therapy, STEROGYL-15, in oil, in alcohol and in drops. Incidentally, VITAMIN D 3 is a booming molecule today. From here on, there was no looking back.
                    pointer FIPPL started Doctor-specific promotions for its pioneering inventions and went on to introduce some of the most popular brands.
                    pointer In 1961, FIPPL reached an agreement with Laboratoires Grimault, France to market their specialties in India and subsequently started its own manufacturing unit in Mumbai. This Company, over the years has developed expertise in the manufacture of products for Diabetes, for the treatment of Vitiligo, Psoriasis & Hepatic disorders. Today, Laboratoires Griffon (earlier Laboratoires Grimault) enjoys a major share in Therapeutic segments like OHAs, Hepatoprotectives and Dermatologicals.
                     
                    pointer FIPPL then established WARDEX PHARMACEUTICALS PVT. LTD. to meet the increasing demand of Dexorange Syrup, the leading Hematinic and also the brand leader in this segment. This Company has manufacturing units at Kolkata in West Bengal, Sahibabad in Uttar Pradesh and Chennai in Tamil Nadu. The objective of this Company was to ensure availability of DEXORANGE SYRUP all over India, keeping logistics of the country in mind.
                    pointer Besides the Anti-anaemic segment, WARDEX PHARMACEUTICALS PVT. LTD. has a strong presence in the field of Bronchodilators and Cough and Cold preparations with their products Grilinctus and Grilinctus BM Syp/Tabs/Paed.Syp. Grilinctus BM is the brand leader in its segment.
                    pointer Then FRANCO-INDIAN REMEDIES PVT. LTD. was established as a manufacturing unit at Chennai and over the years has emerged as a successful tablet manufacturing company.
                     
                     
                     
                     
                     
                     
                     
                     
                         
                     
                      Contact Us | Privacy Policy  
                       
                    宝宝我们在水里做好不好 一个添上面二个?下面